Joseph F. Aceto

Of Counsel
Located in

Philadelphia, PA

“As an intellectual property attorney, I listen to my clients, learn their needs and goals, and help them to establish their IP estate and grow their company’s wealth.”

- Joseph F. Aceto, Ph.D., Of Counsel

“As an intellectual property attorney, I listen to my clients, learn their needs and goals, and help them to establish their IP estate and grow their company’s wealth.”

- Joseph F. Aceto, Ph.D., Of Counsel

As an intellectual property (IP) attorney, Joe works with clients to develop and secure their IP estate, including patents, trademarks, and copyrights. Joe works closely with the client and their technical staff to understand and meet the legal needs of their particular technology. This may include guiding clients through the process of filing a patent and prosecuting the application before the United State Patent and Trademark Office, assessing the strength or validity of a new trademark, filing and prosecuting a new trademark, or working with a client to acquire technology or license their own technology to a third party.

Through his network of attorneys outside the United States, Joe is able to streamline protection both in the U.S. and abroad. He works with clients to protect their current and future IP interests. Further, in collaboration with Obermayer’s litigation group, the firm provides comprehensive protection and enforcement of his client’s IP.

In his free time, Joe is a lifelong Philadelphia Eagles fan, following them through winning seasons, as well as those seasons when the wins were few and far between. He is extremely grateful to have seen the Eagles win a Super Bowl in his lifetime.

Joe is also an avid gardener and is always looking to improve gardening technology. An amateur vintner, Joe makes wine for his family’s personal consumption, always keeping his yearly volume below the statutory requirement for a single family.

Joe’s wife is a veterinarian. So, on any given weekend you may find him helping with an ornery bull, shearing sheep or building a chicken coop.

Joe has worked extensively with biotech companies, pharmaceutical companies and non-profit research institutions. He is a registered patent attorney at the US Patent and Trademark Office (USPTO).

Joe enjoys working with new technology and continues to work with numerous start-up companies, assisting them with their legal needs. As a IP lawyer, he is always on the leading edge of new technology. Joe has a Ph.D. in Pharmacology and spent a portion of his professional life actively involved in medical and biotechnology research. As a lawyer, he is able to integrate that experience in assisting clients, taking on the challenge of establishing and protecting their IP estate.

Some of Joe’s more notable accomplishments include:

  • Worked with the Archdiocese of Philadelphia for the World Meeting of Families to help establish their trademark estate.
  • Successfully obtained a patent on an improvement to Archimedes Screw which, until now, had not changed since antiquity.
  • Provided advice for NFL rookies in branding their image and developing post-career options.
  • Being invited to the Malaysian Embassy in Washington D.C. as a panel member to discuss entrepreneurship and innovation in the US.

Joe is a member of the Board of Directors for the Pennsylvania Drug Discovery Institute. He is also a present or past member of the American Intellectual Property Law Association, the American Society of Pharmacology and Experimental Therapeutics, the Biophysical Society, and the Mid-Atlantic Pharmacology Society.

Complementing Joe’s legal experience, he has been a postdoctoral fellow with Geisinger Clinic, Weis Center for Cardiovascular Research (1987-1989) and employed at the Hoffman-La Roche, Roche Institute of Molecular Biology (1989-1993). Joe has been a lecturer at the University of Pennsylvania providing laboratory research in the study of biochemistry and physiology of cell membranes.

Joe has authored numerous publications on pharmacology, molecular/cell biology, and cardiovascular sciences. After the U.S. Supreme Court decision in Association for Molecular Pathology v. Myriad Genetics, Inc., he was invited to submit a viewpoint for the American Chemical Society’s Medicinal Chemistry Letters on the decision and how the USPTO will interpret patentable subject matter.